Microarray analysis of active cardiac remodeling genes in a familial hypertrophic cardiomyopathy mouse model rescued...

Area of Science:

• Cardiovascular Biology
• Molecular Genetics
• Cardiac Physiology

Background:

• Familial hypertrophic cardiomyopathy (FHC) is a genetic heart disease characterized by ventricular hypertrophy and impaired function.
• Two mouse models were previously developed: one with an FHC-associated α-tropomyosin mutation (Tm180) and a phospholamban knockout (PLN KO).
• Genetic crossing of Tm180 and PLN KO mice resulted in progeny (PLN KO/Tm180) with a rescued hypertrophic phenotype and improved cardiac function.

Purpose of the Study:

• To investigate gene expression changes in cardiac remodeling associated with FHC.
• To identify genes involved in the suppression of the hypertrophic phenotype in the rescued mouse model.
• To understand the molecular mechanisms underlying cardiac remodeling and disease modulation.

Main Methods:

• Microarray analysis of left ventricular tissue from Tm180, PLN KO, PLN KO/Tm180, and control mice at 4 and 12 months of age.
• Gene expression profiling to identify differentially expressed genes across the models.
• Quantitative RT-PCR to confirm microarray findings.

Main Results:

• Expression profiling identified 1,187 genes with altered expression in response to the genetic modifications.
• Eleven gene expression clusters showed normalization in the PLN KO/Tm180 hearts compared to controls.
• Sixty-two transcripts were identified as highly involved in suppressing the hypertrophic phenotype.

Conclusions:

• The study reveals significant alterations in gene expression during cardiac remodeling in FHC models.
• The PLN KO/Tm180 model demonstrates normalization of transcript expression, correlating with rescued cardiac phenotype.
• These findings provide crucial insights into the genetic regulation of hypertrophic cardiomyopathy and identify potential targets for therapeutic intervention.